Oncodesign Precision Medicine (ALOPM)

Last close As at 06/02/2026

EUR0.55

0.01 (2.22%)

Market capitalisation

EUR10m

Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specialised in precision medicine for the treatment of resistant and metastatic cancers.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Philippe Genne

    CEO

  • Karine Lignel

    COO